D.E. Shaw & Co’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.4K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $550K | Sell |
|
|||||
|
2023
Q3 | $855K | Sell |
|
|||||
|
2023
Q2 | $2.78M | Sell |
|
|||||
|
2023
Q1 | $7.15M | Sell |
|
|||||
|
2022
Q4 | $5.88M | Buy |
|
|||||
|
2022
Q3 | $7.31M | Sell |
|
|||||
|
2022
Q2 | $6M | Sell |
|
|||||
|
2022
Q1 | $6.75M | Buy |
|
|||||
|
2021
Q4 | $11.1M | Sell |
|
|||||
|
2021
Q3 | $15.5M | Sell |
|
|||||
|
2021
Q2 | $15.6M | Buy |
|
|||||
|
2021
Q1 | $17.6M | Buy |
|
|||||
|
2020
Q4 | $6.14M | Buy |
|
|||||
|
2020
Q3 | $1.39M | Sell |
|
|||||
|
2020
Q2 | $2.63M | Buy |
|
|||||
|
2020
Q1 | $999K | Buy |
|
|||||
|
2019
Q4 | $676K | Buy |
|
|||||
|
2019
Q3 | $48K | Sell |
|
|||||
|
2019
Q2 | $411K | Sell |
|
|||||
|
2019
Q1 | $1.31M | Sell |
|
|||||
|
2018
Q4 | $1.78M | Buy |
|
|||||
|
2018
Q3 | $1.02M | Buy |
|
|||||
|
2018
Q2 | $932K | Buy |
|
|||||
|
2018
Q1 | $393K | Buy |
|
|||||
|
2017
Q4 | $345K | Buy |
|
|||||
|
2017
Q3 | $389K | Sell |
|
|||||
|
2017
Q2 | $1.9M | Sell |
|
|||||
|
2017
Q1 | $2.42M | Buy |
|
|||||
|
2016
Q4 | $1.22M | Sell |
|
|||||
|
2016
Q3 | $12.1M | Buy |
|
|||||
|
2016
Q2 | $2.83M | Buy |
|
|||||
|
2016
Q1 | $1.01M | Buy |
|
|||||
|
2015
Q4 | $257K | Sell |
|
|||||
|
2015
Q3 | $238K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $11K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $66K | Sell |
|
|||||
|
2013
Q4 | $572K | Buy |
|
|||||
|
2013
Q3 | $635K | Buy |
|
|||||
|
2013
Q2 | $264K | Buy |
|